Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lambumiz raised ₽802 million in its IPO

10/30/24 LMBZ

Aeroflot reported for 9 months of 2024 by RAS

10/30/24 AFLT

Genetico reported for 9 months of 2024 by RAS

10/30/24 GECO

Europlan reported for 9 months of 2024 by RAS

10/30/24 LEAS

MD Medical's revenues grew by 22% in 9 months

10/30/24 MDMG

Rosseti Siberia reported for 9 months of 2024 by RAS

10/30/24 MRKS

Zvezda again postpones delivery of Arc7 tankers for Novatek

10/30/24 NVTK

Magadanenergo reported for 9 months of 2024 by RAS

10/30/24 MAGE

Active customer base of VseInstrumenty.ru grew by 4%

10/30/24 VSEH

Sakhalinenergo reported for 9 months of 2024 by RAS

10/30/24 SLEN